RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
T HELPER 22 CELLS INCREASE IN MULTIPLE SCLEROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION
2010-01-01 Simona Rolla; Valentina Bardina; Marinella Clerico; Luca Durelli; Francesco Novelli
T helper 22 increase in multiple sclerosis patints: phenotypical and functional characterization
2010-01-01 Rolla S; Bardina V; Clerico M; Durelli L; Novelli F
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study
2009-01-01 Luca Durelli; Simona Rolla; Marinella Clerico; Laura Conti; Giulia Contessa; Daniela Boselli; Paolo Ripellino; Emanuela Viglietta; Delon La Puma; Antonio Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Francesco Novelli
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy
2009-01-01 L. DURELLI; S. ROLLA; M. CLERICO; L. CONTI; G. CONTESSA; D. BOSELLI; P. RIPELLINO; E. VIGLIETTA; D. LAPUMA; A. UCCELLI; M. ZAFFARONI; P. CAVALLA; E. RINALDI; C. COMI; F. NOVELLI
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta
2008-01-01 Luca Durelli; Laura Conti; Marinella Clerico; Daniela Boselli; Giulia Contessa; Chiara Rivoiro; Bruno Ferrero; Daniela Viglietti; Paolo Ripellino; Angelo Ghezzi; Mauro Zaffaroni; Francesco Novelli
Testing a high-dose protocol (500 mcg every-other-day, subcutaneously) for interferon beta-1b treatment of ms. Clinical and laboratory tolerability evaluated in a multicentre study
2003-01-01 L. DURELLI; G. GIULIANI; E. MONTANARI; A. PROTTI; E. PUCCI; I.PESCI; L. MANNESCHI; P.BARBERO; A. PIPIERI; M. CLERICO; E. VERDUN
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta
2009-01-01 Novelli. F; Conti L.; Boselli D; Rolla S.; Clerico M.; Contessa G; Durelli L.
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta
2009-01-01 Luca Durelli; Simona Rolla; Marinella Clerico; Laura Conti; Giulia Contessa; paolo Ripellino; Delon La Puma; Emanuela Viglietta; Antonio Uccelli; mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; daniela Boselli; Francesco Novelli
The autoimmunity profile in interferon beta (AUPRIN) study: occurrence of autoimmune events during treatment with two different dosages of subcutaneous interferon beta–1a (REBIF)
2006-01-01 L. DURELLI; P. BARBERO; M. CLERICO; G. CONTESSA; A. PIPIERI; L. GIORDANO; FOR THE AUPRIN STUDY GROUP
The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis
2009-01-01 Clerico, M; Versino, E; Contessa, G; Ripellino, P; Palace, J; Tintore, M; Durelli, L
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
T HELPER 22 CELLS INCREASE IN MULTIPLE SCLEROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION | 2010 | Simona Rolla; Valentina Bardina; Marinella Clerico; Luca Durelli; Francesco Novelli | |
T helper 22 increase in multiple sclerosis patints: phenotypical and functional characterization | 2010 | Rolla S; Bardina V; Clerico M; Durelli L; Novelli F | |
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study | 2009 | Luca Durelli; Simona Rolla; Marinella Clerico; Laura Conti; Giulia Contessa; Daniela Boselli; Paolo Ripellino; Emanuela Viglietta; Delon La Puma; Antonio Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Francesco Novelli | |
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy | 2009 | L. DURELLI; S. ROLLA; M. CLERICO; L. CONTI; G. CONTESSA; D. BOSELLI; P. RIPELLINO; E. VIGLIETTA; D. LAPUMA; A. UCCELLI; M. ZAFFARONI; P. CAVALLA; E. RINALDI; C. COMI; F. NOVELLI | |
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta | 2008 | Luca Durelli; Laura Conti; Marinella Clerico; Daniela Boselli; Giulia Contessa; Chiara Rivoiro; Bruno Ferrero; Daniela Viglietti; Paolo Ripellino; Angelo Ghezzi; Mauro Zaffaroni; Francesco Novelli | |
Testing a high-dose protocol (500 mcg every-other-day, subcutaneously) for interferon beta-1b treatment of ms. Clinical and laboratory tolerability evaluated in a multicentre study | 2003 | L. DURELLI; G. GIULIANI; E. MONTANARI; A. PROTTI; E. PUCCI; I.PESCI; L. MANNESCHI; P.BARBERO; A. PIPIERI; M. CLERICO; E. VERDUN | |
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta | 2009 | Novelli. F; Conti L.; Boselli D; Rolla S.; Clerico M.; Contessa G; Durelli L. | |
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta | 2009 | Luca Durelli; Simona Rolla; Marinella Clerico; Laura Conti; Giulia Contessa; paolo Ripellino; Delon La Puma; Emanuela Viglietta; Antonio Uccelli; mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; daniela Boselli; Francesco Novelli | |
The autoimmunity profile in interferon beta (AUPRIN) study: occurrence of autoimmune events during treatment with two different dosages of subcutaneous interferon beta–1a (REBIF) | 2006 | L. DURELLI; P. BARBERO; M. CLERICO; G. CONTESSA; A. PIPIERI; L. GIORDANO; FOR THE AUPRIN STUDY GROUP | |
The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis | 2009 | Clerico, M; Versino, E; Contessa, G; Ripellino, P; Palace, J; Tintore, M; Durelli, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 137
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 137
Data di pubblicazione
- 2010 - 2017 20
- 2002 - 2009 117
Editore
- Springer-Verlag 53
- Lippincot Williams and Wilkins 14
- SAGE publications 9
- SAGE Publications 8
- SAGE Pubblications 6
- Antonio Federico 5
- Lippincott Williams and Wilkins 4
- Robert A. Gross 4
- Springer 4
- Springer Verlag-Italia 4
Rivista
- JOURNAL OF NEUROLOGY 1
Keyword
- Active learning 1
- Cooperative learning 1
- Flipped classroom 1
- Global education 1
- Global university 1
- INTERFERONI 1
- SCLEROSI MULTIPLA 1
- Student centered teaching methods 1
- TH17 1
- TH22 1
Lingua
- eng 137
Accesso al fulltext
- no fulltext 135
- open 2